United States Diabetes Therapies & Diagnostics Market Report 2016

Global Info Research
124 Pages
Notes:
Sales, means the sales volume of Diabetes Therapies & Diagnostics
Revenue, means the sales value of Diabetes Therapies & Diagnostics

This report studies sales (consumption) of Diabetes Therapies & Diagnostics in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Abbott Diabetes Care
Bayer Health Care
Bio-Rad Laboratories
Nipro Diagnostics
LifeScan Inc
Medtronic MiniMed
Roche Diagnostics
Sanwa Kagaku Kenkyusho
Siemens Healthcare Diagnostics
Novo Nordisk A/S
Becton
BD
Dickinson
Ypsomed Holdings AG
Owen Mumford
HTL-STREFA S.A.
B. Braun Melsungen

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Insulin products
Oral hypoglycemic drugs
Monitoring Device and Accessories
Others
Split by applications, this report focuses on sales, market share and growth rate of Diabetes Therapies & Diagnostics in each application, can be divided into
Diagnostic centers
Hospitals
Home health care
Others

Table of Contents



United States Diabetes Therapies & Diagnostics Market Report 2016

1 Diabetes Therapies & Diagnostics Overview

1.1 Product Overview and Scope of Diabetes Therapies & Diagnostics

1.2 Classification of Diabetes Therapies & Diagnostics

1.2.1 Insulin products

1.2.2 Oral hypoglycemic drugs

1.2.3 Monitoring Device and Accessories

1.2.4 Others

1.3 Application of Diabetes Therapies & Diagnostics

1.3.1 Diagnostic centers

1.3.2 Hospitals

1.3.3 Home health care

1.3.4 Others

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Diabetes Therapies & Diagnostics (2011-2021)

1.4.1 United States Diabetes Therapies & Diagnostics Sales and Growth Rate (2011-2021)

1.4.2 United States Diabetes Therapies & Diagnostics Revenue and Growth Rate (2011-2021)



2 United States Diabetes Therapies & Diagnostics Competition by Manufacturers

2.1 United States Diabetes Therapies & Diagnostics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Diabetes Therapies & Diagnostics Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Diabetes Therapies & Diagnostics Average Price by Manufactures (2015 and 2016)

2.4 Diabetes Therapies & Diagnostics Market Competitive Situation and Trends

2.4.1 Diabetes Therapies & Diagnostics Market Concentration Rate

2.4.2 Diabetes Therapies & Diagnostics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion



3 United States Diabetes Therapies & Diagnostics Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Diabetes Therapies & Diagnostics Sales and Market Share by Type (2011-2016)

3.2 United States Diabetes Therapies & Diagnostics Revenue and Market Share by Type (2011-2016)

3.3 United States Diabetes Therapies & Diagnostics Price by Type (2011-2016)

3.4 United States Diabetes Therapies & Diagnostics Sales Growth Rate by Type (2011-2016)



4 United States Diabetes Therapies & Diagnostics Sales (Volume) by Application (2011-2016)

4.1 United States Diabetes Therapies & Diagnostics Sales and Market Share by Application (2011-2016)

4.2 United States Diabetes Therapies & Diagnostics Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities



5 United States Diabetes Therapies & Diagnostics Manufacturers Profiles/Analysis

5.1 Abbott Diabetes Care

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Abbott Diabetes Care Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Bayer Health Care

5.2.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Bayer Health Care Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bio-Rad Laboratories

5.3.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bio-Rad Laboratories Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Nipro Diagnostics

5.4.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Nipro Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 LifeScan Inc

5.5.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 LifeScan Inc Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Medtronic MiniMed

5.6.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Medtronic MiniMed Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Roche Diagnostics

5.7.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Roche Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Sanwa Kagaku Kenkyusho

5.8.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Sanwa Kagaku Kenkyusho Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Siemens Healthcare Diagnostics

5.9.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Siemens Healthcare Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Novo Nordisk A/S

5.10.2 Diabetes Therapies & Diagnostics Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Novo Nordisk A/S Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Becton

5.12 BD

5.13 Dickinson

5.14 Ypsomed Holdings AG

5.15 Owen Mumford

5.16 HTL-STREFA S.A.

5.17 B. Braun Melsungen



6 Diabetes Therapies & Diagnostics Manufacturing Cost Analysis

6.1 Diabetes Therapies & Diagnostics Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Diabetes Therapies & Diagnostics



7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Diabetes Therapies & Diagnostics Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Diabetes Therapies & Diagnostics Major Manufacturers in 2015

7.4 Downstream Buyers



8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List



9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change



10 United States Diabetes Therapies & Diagnostics Market Forecast (2016-2021)

10.1 United States Diabetes Therapies & Diagnostics Sales, Revenue Forecast (2016-2021)

10.2 United States Diabetes Therapies & Diagnostics Sales Forecast by Type (2016-2021)

10.3 United States Diabetes Therapies & Diagnostics Sales Forecast by Application (2016-2021)

10.4 Diabetes Therapies & Diagnostics Price Forecast (2016-2021)



11 Research Findings and Conclusion



12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer




List of Tables and Figures



Figure Picture of Diabetes Therapies & Diagnostics

Table Classification of Diabetes Therapies & Diagnostics

Figure United States Sales Market Share of Diabetes Therapies & Diagnostics by Type in 2015

Figure Insulin products Picture

Figure Oral hypoglycemic drugs Picture

Figure Monitoring Device and Accessories Picture

Figure Others Picture

Table Application of Diabetes Therapies & Diagnostics

Figure United States Sales Market Share of Diabetes Therapies & Diagnostics by Application in 2015

Figure Diagnostic centers Examples

Figure Hospitals Examples

Figure Home health care Examples

Figure Others Examples

Figure United States Diabetes Therapies & Diagnostics Sales and Growth Rate (2011-2021)

Figure United States Diabetes Therapies & Diagnostics Revenue and Growth Rate (2011-2021)

Table United States Diabetes Therapies & Diagnostics Sales of Key Manufacturers (2015 and 2016)

Table United States Diabetes Therapies & Diagnostics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Diabetes Therapies & Diagnostics Sales Share by Manufacturers

Figure 2016 Diabetes Therapies & Diagnostics Sales Share by Manufacturers

Table United States Diabetes Therapies & Diagnostics Revenue by Manufacturers (2015 and 2016)

Table United States Diabetes Therapies & Diagnostics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Diabetes Therapies & Diagnostics Revenue Share by Manufacturers

Table 2016 United States Diabetes Therapies & Diagnostics Revenue Share by Manufacturers

Table United States Market Diabetes Therapies & Diagnostics Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Diabetes Therapies & Diagnostics Average Price of Key Manufacturers in 2015

Figure Diabetes Therapies & Diagnostics Market Share of Top 3 Manufacturers

Figure Diabetes Therapies & Diagnostics Market Share of Top 5 Manufacturers

Table United States Diabetes Therapies & Diagnostics Sales by Type (2011-2016)

Table United States Diabetes Therapies & Diagnostics Sales Share by Type (2011-2016)

Figure United States Diabetes Therapies & Diagnostics Sales Market Share by Type in 2015

Table United States Diabetes Therapies & Diagnostics Revenue and Market Share by Type (2011-2016)

Table United States Diabetes Therapies & Diagnostics Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Diabetes Therapies & Diagnostics by Type (2011-2016)

Table United States Diabetes Therapies & Diagnostics Price by Type (2011-2016)

Figure United States Diabetes Therapies & Diagnostics Sales Growth Rate by Type (2011-2016)

Table United States Diabetes Therapies & Diagnostics Sales by Application (2011-2016)

Table United States Diabetes Therapies & Diagnostics Sales Market Share by Application (2011-2016)

Figure United States Diabetes Therapies & Diagnostics Sales Market Share by Application in 2015

Table United States Diabetes Therapies & Diagnostics Sales Growth Rate by Application (2011-2016)

Figure United States Diabetes Therapies & Diagnostics Sales Growth Rate by Application (2011-2016)

Table Abbott Diabetes Care Basic Information List

Table Abbott Diabetes Care Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Diabetes Care Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Bayer Health Care Basic Information List

Table Bayer Health Care Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer Health Care Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Bio-Rad Laboratories Basic Information List

Table Bio-Rad Laboratories Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bio-Rad Laboratories Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Nipro Diagnostics Basic Information List

Table Nipro Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nipro Diagnostics Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table LifeScan Inc Basic Information List

Table LifeScan Inc Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table LifeScan Inc Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Medtronic MiniMed Basic Information List

Table Medtronic MiniMed Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Medtronic MiniMed Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Roche Diagnostics Basic Information List

Table Roche Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Roche Diagnostics Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Sanwa Kagaku Kenkyusho Basic Information List

Table Sanwa Kagaku Kenkyusho Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanwa Kagaku Kenkyusho Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Siemens Healthcare Diagnostics Basic Information List

Table Siemens Healthcare Diagnostics Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Siemens Healthcare Diagnostics Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Novo Nordisk A/S Basic Information List

Table Novo Nordisk A/S Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk A/S Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Becton Basic Information List

Table Becton Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Becton Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table BD Basic Information List

Table BD Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table BD Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Dickinson Basic Information List

Table Dickinson Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Dickinson Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Ypsomed Holdings AG Basic Information List

Table Ypsomed Holdings AG Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ypsomed Holdings AG Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Owen Mumford Basic Information List

Table Owen Mumford Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Owen Mumford Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table HTL-STREFA S.A. Basic Information List

Table HTL-STREFA S.A. Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table HTL-STREFA S.A. Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table B. Braun Melsungen Basic Information List

Table B. Braun Melsungen Diabetes Therapies & Diagnostics Sales, Revenue, Price and Gross Margin (2011-2016)

Table B. Braun Melsungen Diabetes Therapies & Diagnostics Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Diabetes Therapies & Diagnostics

Figure Manufacturing Process Analysis of Diabetes Therapies & Diagnostics

Figure Diabetes Therapies & Diagnostics Industrial Chain Analysis

Table Raw Materials Sources of Diabetes Therapies & Diagnostics Major Manufacturers in 2015

Table Major Buyers of Diabetes Therapies & Diagnostics

Table Distributors/Traders List

Figure United States Diabetes Therapies & Diagnostics Production and Growth Rate Forecast (2016-2021)

Figure United States Diabetes Therapies & Diagnostics Revenue and Growth Rate Forecast (2016-2021)

Table United States Diabetes Therapies & Diagnostics Production Forecast by Type (2016-2021)

Table United States Diabetes Therapies & Diagnostics Consumption Forecast by Application (2016-2021)



captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

North America X-ray Detectors Market by Manufacturers, Countries, Type and Application, Forecast to 2022

GIR 2017-11-21 Pharma & Healthcare

X-ray detectors are devices use a scintillator to convert x-rays into visible light. They are used t...Read More

North America Animal Stem Cell Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2022

GIR 2017-11-21 Pharma & Healthcare

Animal stem cell therapy is a usage of animal s stem cell to treat a disease or disorder. The abilit...Read More

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Vitamin Market 2017 Forecast to 2022

GIR 2017-11-21 Pharma & Healthcare

Vitamin is a huge family, now known as vitamins have a few kinds, can divide roughly for fat-soluble...Read More

Report's License Type

$3800
$7600

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.